We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

The rapidly rising premium for Part B, which covers retirees’ outpatient services, reflects the fast pace of growth for health care costs nationally. By Mark Miller If you’re enrolled in Medicare, you ...

Medicare Part D and Medicare Advantage are changing in 2026. Learn how these updates could impact your prescription costs and coverage options. JD Vance responds to "illegal orders" argument from ...

Toni King has authored several books on the subject of Medicare and has appeared regularly as a guest on the American Family Radio Network. You helped me sign up for a Medicare Supplement Plan G and a ...

Fall enrollment is on. Some plans are raising premiums for Part D, which covers prescriptions, by $50 or more per month, while others are lowering them. By Mark Miller Holly Kluck found a great price ...

This article is part of a Health Affairs Forefront featured series, “Assessing The Evidence For MA Reform.” The series was developed and supported by the research firm, Stage Analytics, through a ...

Listen and subscribe to Decoding Retirement on Apple Podcasts, Spotify, or wherever you find your favorite podcasts. Nearly all of the 55 million Medicare beneficiaries enrolled in Part D prescription ...

The current state of the Medicare Part D market is a mixed bag, with premiums declining but many payers scaling back options, according to a new analysis from KFF. The report noted that the Centers ...

Aetna is a health insurance company selling one Medicare Part D prescription drug plan in 2026 in 49 states and Washington, D.C. That said, the monthly premiums, copays, and deductibles can vary ...

Please provide your email address to receive an email when new articles are posted on . Medicare Part D beneficiaries had an increase in out-of-pocket spending for GLP-1s approved for diabetes in 2025 ...

A cross-sectional study found that while the Inflation Reduction Act capped out-of-pocket drug costs for Medicare Part D beneficiaries at $2,000 starting in 2025, many enrollees may still face higher ...